Description
WHOLE BLOOD AND BLOOD PRODUCTS
Base award description: WHOLE BLOOD AND BLOOD PRODUCTS 673-C90341
Modification chain · 5 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2009-01-30+$1,725,674= $1,725,674
- Mod 12009-03-02+$0= $1,725,674
- Mod 22009-12-31+$208,000= $1,933,674
- Mod 32010-01-30+$416,000= $2,349,674
- Mod 42010-03-19+$239,132= $2,588,806
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2009-01-30 | +$1,725,674 | $1,725,674 | WHOLE BLOOD AND BLOOD PRODUCTS 673-C90341 |
| Mod 1· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2009-03-02 | +$0 | $1,725,674 | IT REQUIREMENTS MOD |
| Mod 2· EXERCISE AN OPTION | 2009-12-31 | +$208,000 | $1,933,674 | WHOLE BLOOD PRODUCTS-OPT TO EXTEND SERVICE THRU 1/31/10 |
| Mod 3· EXERCISE AN OPTION | 2010-01-30 | +$416,000 | $2,349,674 | BLOOD AND BLOOD PRODUCTS-EXERCISE OPT TO EXT THRU 3/31/10 VA673-C00292 |
| Mod 4· EXERCISE AN OPTION | 2010-03-19 | +$239,132 | $2,588,806 | WHOLE BLOOD AND BLOOD PRODUCTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI SX3XGHRJMNQ5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24826N0419 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $792,973 | FY2026 |
| 36C24826N0399 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6506 · BLOOD AND BLOOD PRODUCTS | $354,763 | FY2026 |
| 36C24826N0424 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $268,659 | FY2026 |
| 36C24826N0400 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $314,881 | FY2026 |
| 36C24826N0347 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $619,287 | FY2026 |
| 36C24826D0015 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under Q999 from 673-TAMPA (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA248BP00880065 | ISLAND COAST ORTHOPEDICS, INC | 673-TAMPA | $0 | FY2012 |
| VA673C20016 | AGENCY FOR COMMUNITY TREATMENT SERVICES, INC | 673-TAMPA | $69,120 | FY2012 |
| VA673C10615 | ACTELION PHARMACEUTICALS US, INC. | 673-TAMPA | $8,796 | FY2011 |
| VA673C10498 | AGENCY FOR COMMUNITY TREATMENT SERVICES, INC | 673-TAMPA | $22,320 | FY2011 |
| VA573C12880 | UNIVERSITY OF FLORIDA | 673-TAMPA | $54,180 | FY2011 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA248P0918_3600_-NONE-_-NONE- · retrieved 2026-09-26.